25
Views
10
CrossRef citations to date
0
Altmetric
Symposium: Controversies in Pediatric Ophthalmology and Orthoptics: A Point-Counterpoint Discussion

Infantile Hemangioma: Treatment with Surgery or Steroids

, M.D.
Pages 6-13 | Published online: 22 Dec 2017

References

  • Haik BG, Karcioglu ZA, Gordon RA, Pechous BP: Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmol 1994; 38: 399–426.
  • Holland KE, Drolet BA: Infantile hemangioma. Pediatr Clin North Am 2010; 57: 1069–1083.
  • Schwartz SR, Blei F, Ceisler E, Steele M, Furlan L, Kodsi S: Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS 2006; 10: 262–268.
  • Frank RC, Cowan BJ, Harrop AR, Astle WF, McPhalen DF: Visual development in infants: Visual complications of periocular haemangiomas. J Plast Reconstr Aesthet Surg 2010; 63: 1–8.
  • Weiss AH, Kelly JP: Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology 2008; 115: 390–397 e1.
  • Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A: Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649–2651.
  • Guo S, Hunt MG, Superstein R: Treatment of infantile hemangiomas. J Pediatr Ophthalmol Strabismus 2010; 47: 198–201.
  • Ni N, Langer P, Wagner R, Guo S: Topical timolol for periocular hemangioma: Report of further study. Arch Ophthalmol 2011; 129: 377–379.
  • Léauté-Labrèze C, Taieb A: [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences] (in French). Ann Dermatol Venereol 2008; 135: 860–862.
  • Siegfried EC, Keenan WJ, Al-Jureidini S: More on propranolol for hemangiomas of infancy. N Engl J Med 2008; 359: 2846, author reply 46-47.
  • Taban M, Goldberg RA: Propranolol for orbital hemangioma. Ophthalmology 2010; 117: 195–195 e4.
  • Cheng JF, Gole GA, Sullivan TJ: Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010; 38: 547–553.
  • Fabian ID, Ben-Zion I, Samuel C, Spierer A: Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. Am J Ophthalmol 2011; 151: 53–58.
  • Fridman G, Grieser E, Hill R, Khuddus N, Bersani T, Slonim C: Propranolol for the treatment of orbital infantile hemangiomas. Ophthal Plast Reconstr Surg 2011; 27: 190–194.
  • Meena M: Re: “propranolol for the treatment of orbital infantile hemangiomas”. Ophthal Plast Reconstr Surg 2011; 27: 392, author reply 93.
  • Bagazgoitia L, Hernandez-Martin A, Torrelo A: Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 2011; 28: 658–662.
  • Frieden IJ, Drolet BA: Propranolol for infantile hemangiomas: Promise, peril, pathogenesis. Pediatr Dermatol 2009; 26: 642–644.
  • Plager DA, Snyder SK: Resolution of astigmatism after surgical resection of capillary hemangiomas in infants. Ophthalmology 1997; 104: 1102–1106.
  • Levi M, Schwartz S, Blei F, Ceisler E, Steele M, Furlan L: Surgical treatment of capillary hemangiomas causing amblyopia. J AAPOS 2007; 11: 230–234.
  • Arneja JS, Mulliken JB: Resection of amblyogenic periocular hemangiomas: Indications and outcomes. Plast Reconstr Surg 2010; 125: 274–281.
  • Walker RS, Custer PL, Nerad JA. Surgical excision of periorbital capillary hemangiomas. Ophthalmology 1994; 101: 1333–1340.
  • Aldave AJ, Shields CL, Shields JA: Surgical excision of selected amblyogenic periorbital capillary hemangiomas. Ophthalmic Surg Lasers 1999; 30: 754–757.
  • Deans RM, Harris GJ, Kivlin JD: Surgical dissection of capillary hemangiomas. An alternative to intralesional corticosteroids. Arch Ophthalmol 1992; 110: 1743–1747.
  • Slaughter K, Sullivan T, Boulton J, O'Reagan P, Gole G: Early surgical intervention as definitive treatment for ocular adnexal capillary haemangioma. Clin Experiment Ophthalmol 2003; 31: 418–423.
  • Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T: Propranolol treatment for severe infantile hemangiomas: A singlecentre 3-year experience. Acta Paediatr 2012; 101: e469–474.
  • Balma-Mena A, Chakkittakandiyil A, Weinstein M, Lansang P, Ho N, Cammisuli S: Propranolol in the management of infantile hemangiomas: Clinical response and predictors. J Cutan Med Surg 2012; 16: 169–173.
  • Talaat AA, Elbasiouny MS, Elgendy DS, Elwakil TF: Propranolol treatment of infantile hemangioma: Clinical and radiologic evaluations. J Pediatr Surg 2012; 47: 707–714.
  • Lv MM, Fan XD, Su LX: Propranolol for problematic head and neck hemangiomas: An analysis of 37 consecutive patients. Int J Pediatr Otorhinolaryngol 2012; 76: 574–578.
  • Schupp CJ, Kleber JB, Gunther P, Holland-Cunz S: Propranolol therapy in 55 infants with infantile hemangioma: Dosage, duration, adverse effects, and outcome. Pediatr Dermatol 2011; 28: 640–644.
  • Snir M, Reich U, Siegel R, Zvulunov A, Friling R, Goldenberg-Cohen N: Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye (Lond) 2011; 25: 1627–1634.
  • Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT: Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope 2010; 120: 676–681.
  • Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J: Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009; 124: e423–431.
  • Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R: Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011; 170: 493–501.
  • Manunza F, Syed S, Laguda B, Linward J, Kennedy H, Gholam K: Propranolol for complicated infantile haemangiomas: A case series of 30 infants. Br J Dermatol 2010; 162: 466–468.
  • Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA: Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775–778.
  • de Graaf M, Breur JM, Raphael MF, Vos M, Breugem CC, Pasmans SG: Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol 2011; 65: 320–327.
  • Mihov Y, Mayer S, Musshoff F, Maier W, Kendrick KM, Hurlemann R: Facilitation of learning by social-emotional feedback in humans is betanoradrenergic-dependent. Neuropsychologia 2010; 48: 3168–3172.
  • Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C: Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychol Med 2010; 40: 1839–1848.
  • Rossler J, Schill T, Bahr A, Truckenmuller W, Noellke P, Niemeyer CM: Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy: A retrospective, single centre study. J Eur Acad Dermatol Venereol 2012; 26: 1173–1175.
  • Janmohamed SR, Madern GC, Nieuwenhuis K, de Laat PC, Oranje AP: Evaluation of intralesional corticosteroids in the treatment of periocular haemangioma of infancy: Still an alternative besides propranolol. Pediatr Surg Int 2012; 28: 393–398.
  • Geh JL, Geh VS, Jemec B, Liasis A, Harper J, Nischal KK: Surgical treatment of periocular hemangiomas: A single-center experience. Plast Reconstr Surg 2007; 119: 1553–1562.
  • Haik BG, Jakobiec FA, Ellsworth RM, Jones IS: Capillary hemangioma of the lids and orbit: An analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology 1979; 86: 760–792.
  • Robb RM: Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol 1977; 83: 52–58.
  • Ranchod TM, Frieden IJ, Fredrick DR: Corticosteroid treatment of periorbital haemangioma of infancy: A review of the evidence. BJO 2005; 89: 1134–1138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.